Orencia vs Humira
Abatacept vs Adalimumab · Comparison Guide
Quick Comparison
| Feature | Orencia | Humira |
|---|---|---|
| Generic Name | Abatacept | Adalimumab |
| Manufacturer | Bristol-Myers Squibb | AbbVie |
| Drug Class | T-Cell Costimulation Modulator | TNF-alpha Inhibitor |
| Shared Conditions | Rheumatoid Arthritis | |
Key Differences: Orencia vs Humira
Orencia works differently than TNF inhibitors — it modulates T-cell activation rather than blocking TNF. For RA, both are effective but Orencia may be preferred in patients who have failed a TNF inhibitor, have concomitant COPD, or where infection risk is a concern. Humira has a broader indication set. Orencia has a favorable safety profile without the malignancy signal seen with some TNF inhibitors.
💊 Orencia (Abatacept)
- Class: T-Cell Costimulation Modulator
- Manufacturer: Bristol-Myers Squibb
- Full Orencia information →
💊 Humira (Adalimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: AbbVie
- Full Humira information →
Orencia works differently than TNF inhibitors — it modulates T-cell activation rather than blocking TNF. For RA, both are effective but Orencia may be preferred in patients who have failed a TNF inhibitor, have concomitant COPD, or where infection risk is a concern. Humira has a broader indication set. Orencia has a favorable safety profile without the malignancy signal seen with some TNF inhibitors.
Neither Orencia nor Humira is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Orencia and Humira are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Orencia and Humira both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Orencia and Humira
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Orencia and Humira should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.